(Reuters) -British bootmaker Dr Martens reported a narrower first-half loss on Thursday, primarily supported by higher sales in the Americas, and maintained its fiscal 2026 forecast despite flagging potential impact of U.S. tariffs. The company, best known for its chunky-lace up boots and now expanding into shoes, sandals, and bags under CEO Ije Nwokorie's new strategy, said tariff-related costs will reach the high single-digit millions of pounds in the current fiscal year. Dr Martens reported adjusted pretax loss of 9.2 million pounds ($12 million) for the six-month period ended September 28, compared with 16.6 million pounds last year. ($1 = 0.7657 pounds) (Reporting by Simone Lobo and Shashwat Awasthi in Bengaluru; Editing by Sherry Jacob-Phillips)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
